Patents Assigned to Preelumina Diagnostics AB
  • HbF AND A1M AS EARLY STAGE MARKERS FOR PREECLAMPSIA
    Publication number: 20130122529
    Abstract: A method for diagnosing or predicting the risk of developing preeclampsia by measuring the level of A1 M and one or more of the compounds HbA, HbF in a sample and comparing the obtained values with reference values. By using a combination of information relating to A1 M and HbF improved diagnose or prediction is observed.
    Type: Application
    Filed: March 24, 2011
    Publication date: May 16, 2013
    Applicant: Preelumina Diagnostics AB
    Inventors: Bo Akerstrom, Magnus Gram, Stefan Hansson